Ambili Menon
Ambili Menon, PhD, is senior manager, scientific affairs at bioMérieux. Email: ambili.menon@biomerieux.com
Articles
Optimizing Testing in Cell and Gene Therapy
September 22nd 2025The scaled adoption of cell and gene therapies demands a new era of agile, precise, and efficient quality control methods. Manufacturers and diagnostic partners must collaborate to create innovative, compliant testing strategies that preserve product integrity, meet tight timelines, and deliver life-saving treatments faster.
Latest Updated Articles
Published: October 11th 2024 | Updated: March 3rd 2025
Exploring New Advancements in ADC Technologies (CPHI Milan 2024)
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: September 22nd 2025 | Updated: September 25th 2025
White Paper: Biopharma PAT Quality Attributes, Critical Process Parameters & Key Performance Indicators at the Bioreactor
Published: September 18th 2025 | Updated: September 25th 2025
From Molecule to Formulation: A Systematic Approach to Assess Biologics Developability
Published: September 10th 2025 | Updated: September 25th 2025
Behind the Headlines Episode 24: Surging Implementation of Sequence Event Reporting in CMC Analytics, Billion Dollar Deals Push Further Consolidation or Collapse, and an Analytics Wish List
